QR Kodea

Cost of Intralesional Collagenase Clostridium Histiolyticum Therapy Versus Surgery for the Management of Peyronie's Disease: A Claims-Based Analysis (2009–2019)

Background: Collagenase Clostridium histolyticum (CCH), which was approved by the FDA for the treatment of Peyronie's disease (PD) in 2013, may obviate the need for surgery but its historically high cost must be considered when offering CCH vs surgical intervention to affected patients. Aim: To comp...

Deskribapen osoa

Gorde:
Egile Nagusiak: Eric L. Walton, MD, Timothy P. Quinn, MD, Evan Mulloy, MD, Dattatraya Patil, MBBS, MPH, Akanksha Mehta, MD, MS
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2022-06-01
Saila:Sexual Medicine
Gaiak:
Peyronie's Disease
Cost Analysis
Intralesional Collagenase
Surgical Plication
Plaque Grafting
Sarrera elektronikoa:http://www.sciencedirect.com/science/article/pii/S2050116122000319
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak